- 基本信息
导师姓名:
|
范瑛
|
学科代码:
|
100201
|
|
性别:
|
女
|
学科名称:
|
内科学
|
培养单位:
|
附属第六人民医院
|
三级学科
|
肾病
|
导师类型:
|
博士生导师
|
专业领域名称:
|
内科学 专业学位
|
联系方式:
|
|
专业领域代码:
|
105101
|
邮编:
|
|
邮箱地址:
|
fanyingsh@126.com
|
- 研究方向 (点击浏览详细信息)
- 社会任职
|
上海市医学会肾脏病分会委员兼秘书
|
中国非公立医疗机构协会肾病专委会委员
|
上海市中西医结合学会肾病专委会委员
|
上海市中西医结合学会养生学专委会常委
|
中国医师协会第十一届肾脏病分会青委会副主任委员
|
上海市肾脏病西部学组秘书
|
- 科研项目
Z-2017-26-2202-2 | SGLT2抑制线粒体相关内质网膜(MAMs)形成诱导糖尿病肾病肾小管损伤的机制研究 | 中华国际医学交流基金会专项基金 |
2023-01~2025-12
|
10万元
| 课题负责人 |
YG2023ZD21 | 基于肾脏病理的糖尿病肾病人工智能辅助诊断系统建立及多模态的预后预测模型研究 | 上海交通大学“交大之星”计划医工交叉重点项目 |
2023-01~2026-12
|
100万元
| 课题负责人 |
ynxg202202 | 血液透析合并新冠病毒感染患者的肺部影像学特征和疾病预测模型构建——多中心、前瞻性、队列研究 | 上海市第六人民医院抗击新冠肺炎疫情应急专题项目 |
2022-05~2023-12
|
10万元
| 课题负责人 |
82170727 | GLP-1R/Nrf2通过抑制RTN1A介导的内质网应激保护糖尿病肾病肾小管损伤的机制研究 | 国家自然科学基金面上项目 |
2022-01~2025-12
|
53万元
| 课题负责人 |
TMSK-2021-109 | 基于人工智能的肾脏病理辅助诊断系统研发及其对糖尿病肾病进展和预后的评价研究 | 上海交通大学转化医学国家重大科技基础设施(上海)开放课题 |
2021-07~2023-06
|
9万元
| 课题负责人 |
JYJX200037 | 缓和医疗在临床医学教育中的现状调查及其在终末期肾病专科治疗中的价值探讨 | 上海交大医学院 |
2020-03~2021-02
|
0.5万元
| 课题负责人 |
20192833 | 中国2型糖尿病肾病人群肾脏全基因组测序分析及疾病相关的调控机制研究 | 上海交通大学医学院“临床专职科研队伍“人才计划 |
2019-10~2022-09
|
100万元
| 课题负责人 |
81870468 | RTN1A介导的内质网应激在“缺血再灌注”导致急性肾损伤 向慢性肾脏病进展中的作用和机制研究 | 国家自然基金面上项目 |
2019-01~2022-12
|
57万元
| 课题负责人 |
SHKSDB-KF-19-04 | Wnt5a/JNK信号通路调控慢性间歇性低氧所致肾脏损伤的机制研究 | 上海市睡眠呼吸障碍疾病重点实验室开放课题 |
2019-01~2020-12
|
5万元
| 课题负责人 |
SHKSDB-KF-19-04 | Wnt5a/JNK信号通路调控慢性间歇性低氧所致肾脏损伤的机制研究 | 上海市睡眠呼吸障碍疾病重点实验室开放课题 |
2019-01~2020-12
|
5万元
| 子课题负责人 |
YG2017MS10 | Wnt5a/CD146信号通路调控急性肾损伤和上皮细胞间充质转变的机制研究 | 交通大学医工交叉面上项目基金 |
2018-01~2020-12
|
24万元
| 课题负责人 |
81670657 | CD146参与Wnt5a/JNK信号通路及其对糖尿病肾病足细胞损伤和上皮间充质转变现象的作用机制研究 | 国家自然科学基金面上项目 |
2017-01~2020-12
|
58万元
| 课题参与人 |
15020140602 | CD146参与Wnt 信号通路及其对糖尿病肾病足细胞损伤的作用机制探讨 | 中华医学会临床科研专项基金 |
2016-01~2018-12
|
5万元
| 课题负责人 |
81400735 | Reticulon-1介导的内质网应激在糖尿病肾病发病机制中的作用 | 国家自然科学基金青年基金 |
2015-01~2017-12
|
25万元
| 课题负责人 |
院10133 | 糖尿病肾病进展过程中足细胞损伤及机制研究 | 上海市六人民医院-阿斯利康(中国)投资有限公司横向合作基金 |
2015-01~2018-12
|
80万元
| 课题参与人 |
- 学术论文
Li He, Ze Li, Qunzi Zhang, Yini Chen, Yihui Gao, Teng Chen, Niansong Wang, Lixin Jiang,
|
Evaluation of renal microperfusion in hyperuricemic nephropathy by contrast-enhanced ultrasound imaging
|
Dis Model Mech
|
2022
|
15(7): dmm049382
|
Ting Zhou, Li Shen, Ze Li, Junjie Jia, Haifan Xing, Niansong Wang, Qiong Jiao,
|
Severe 25-Hydroxyvitamin D deficiency may predict poor renal outcomes in patients with biopsy-proven Diabetic Nephropathy
|
Front Endocrinol
|
2022
|
13:871571
|
Ting Zhou, Yiyun Wang, Li Shen, Xiaomei Li, Qiong Jiao, Ze Li, Junjie Jia, Li He, Qunzi Zhang, Niansong Wang,
|
Clinical and Histological Predictors of Renal Survival in Patients with Biopsy-Proven Diabetic Nephropathy
|
Kidney Dis (Basel)
|
2021
|
DOI: 10.1159/000518222
|
Li X, Wen J, Dong Y, Zhang Q, Guan J, Liu F, Zhou T, Li Z,, Wang N.
|
Wnt5a promotes renal tubular inflammation in diabetic nephropathy by binding to CD146 through noncanonical Wnt signaling
|
Cell Death Dis
|
2021
|
18;12(1):92
|
Wang Y, Zhou T, Zhang Q, Fei Y, Li Z, Li S, He L, Zhang Q, Dong Y,, Wang N. Poor Renal and Cardiovascular Outcomes in Patients with Biopsy-Proven Diabetic Nephropathy
|
Poor Renal and Cardiovascular Outcomes in Patients with Biopsy-Proven Diabetic Nephropathy
|
Kidney Blood Press Res
|
2020
|
25:1-13
|
Zhang Q, He L, Dong Y, Fei Y, Wen J, Li X, Guan J, Liu F, Zhou T, Li Z,, Wang N
|
Sitagliptin ameliorates renal tubular injury in diabetic kidney disease via STAT3-dependent mitochondrial homeostasis through SDF-1α/CXCR4 pathway
|
FASEB J
|
2020
|
34(6):7500-7519
|
Dong Y, Zhang Q, Wen J, Chen T, He L, Wang Y, Yin J, Wu R, Xue R, Li S,, Wang N.
|
Ischemic Duration and Frequency Determines AKI-to-CKD Progression Monitored by Dynamic Changes of Tubular Biomarkers in IRI Mice
|
Front Physiol
|
2019
|
26(10):153
|
, Yi Z, D'Agati VD, Sun Z, Zhong F, Zhang W, Wen J, Zhou T, Li Z, He L, Zhang Q, Lee K, He JC, Wang N.
|
Comparison of Kidney Transcriptomic Profiles of Early and Advanced Diabetic Nephropathy Reveals Potential New Mechanisms for Disease Progression. Diabetes
|
Diabetes
|
2019
|
68(12):2301-2314
|
, Fei Y, Zheng L, Wang J, Xiao W, Wen J, Xu Y, Wang Y, He L, Guan J, Wei J, He JC, Wang N.
|
Expression of Endothelial Cell Injury Marker Cd146 Correlates with Disease Severity and Predicts the Renal Outcomes in Patients with Diabetic Nephropathy.
|
Cell Physiol Biochem
|
2018
|
48(1):63-74
|
He L,, Xiao W, Chen T, Wen J, Dong Y, Wang Y, Li S, Xue R, Zheng Li, He JC, Wang N
|
Febuxostat attenuates ER Stress mediated kidney Injury in a rat model of hyperuricemic nephropathy.
|
Oncotarget
|
2017
|
8(67):111295-111308
|
, Xiao W, Lee K, Salem F, Wen J, He L, Zhang J, Fei Y, Cheng D, Bao H, Liu Y, Lin F, Jiang G, Guo Z, Wang N, He JC.
|
Inhibition of Reticulon-1A-Mediated Endoplasmic Reticulum Stress in Early AKI Attenuates Renal Fibrosis Development.
|
J Am Soc Nephrol
|
2017
|
doi:10.1681/ASN.2016091001
|
, Zhang J, Xiao W, Lee K, Li Z, Wen J, He L, Gui D, Xue R, Jian G, Sheng X, He JC, Wang N.
|
RTN1A-mediated endoplasmic reticulum stress in podocyte injury and diabetic nephropathy.
|
Sci Rep
|
2017
|
7(1): 323
|
, Lee K, Wang N, He JC.
|
The Role of Endoplasmic Reticulum Stress in Diabetic Nephropathy.
|
Curr Diabetes Rep.
|
2017
|
17(3): 17
|
Xiao W,, Wang N, Chuang PY, Lee K, He JC.
|
Knockdown of RTN1A attenuates ER stress and kidney injury in albumin overload-induced nephropathy.
|
Am J Physiol Renal Physiol
|
2016
|
310(5): F409-15
|
, Xiao W, Li Z, Li X, Chuang PY, Jim B, Zhang W, Wei C, Wang N, Jia W, Xiong H, Lee K, He JC.
|
RTN1 mediates progression of kidney disease by inducing ER stress.
|
Nat Commun
|
2015
|
31(6): 7841
|
, Li X, Xiao W, Fu J, Harris RC, Lindenmeyer M, Cohen CD, Guillot N, Baron MH, Wang N, Lee K, He JC, Schlondorff D, Chuang PY.
|
BAMBI elimination enhances non-canonical glomerular ERK1/2 and Smad1/5 signaling and glomerular dysfunction in diabetic mice.
|
Diabetes
|
2015
|
64(6): 2220-33
|
, Wang N, Chuang P, He JC.
|
Role of HIPK2 in kidney fibrosis.
|
Kidney Int Suppl.
|
2014
|
4: 97-101
|
, Wei C, Xiao W, Zhang W, Wang N, Chuang PY, He JC.
|
Temporal profile of the renal transcriptiome of HIV-1 transgenic mice during disease progression.
|
PLoS One
|
2014
|
9(3): e93019
|
|